Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

NCT06430411 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06430411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06430411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2024
Completion date
December 31, 2031
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastasis, oligometastatic disease, prostate cancer, prostate cancer metastatic, prostate cancer metastatic to bone, prostate neoplasm